PAUL-MIKI RALUCHUKWU IBEKWE

• Conducted customer analysis for key product portfolios that uncovered actionable insights that will achieve 12% CAGR in 5 years
• Designed a demand model for company's biopharma global market through collection, analysis and visualization of macroeconomic quantitative and qualitative data that identified current and future market sizes and growth rates. This model was used to design a marketing strategy that ensured 18% cutback in expenses
• Utilized Excel, PowerBI and Tableau reporting tools to build reports and dashboards that enabled data driven insights and decision making
• Conducted primary and secondary market research to identify industry-wide and company-specific new growth opportunities and threats, as well as market trends and challenges for the Pharma Generic Mass Spectrometry business segment. This was used to design a market strategy setup to increase market share by 15%.

• Assisted 2 biotech start-ups to grow into de-risked companies and advance their product commercialization spectrum
• Led and organized Sanofi's iAward and iDEA-iTECH pitch visit to the institute.

• Achieved significant portfolio sales growth in my market segment of 39% TD by redesigning the market's business strategy. This design was driven primarily by data-driven decisions and analysis.
• Built effective and sustainable relationships with prescribers and customers and was awarded NN English West Africa Business Unit (EWABU) Best Group Detailing Execution H1 (First half year) 2021.
• Outstanding for upholding cross-functional collaboration, business ethics and the NN culture, I was appointed NN Middle Africa ambassador for compliance and ethics.
• Through studying educational and scientific materials, I demonstrated first-rate product and industry knowledge, including regulatory, clinical, pharmacokinetics, pharmacodynamics and market intelligence, and won the NN Middle Africa Academy award 2020.
• Achieved a cumulative average of 96% on all measured KPIs for employees. Awarded NN Middle Africa Super Star Employee Q2 2023
• Organized and executed with 97% average attendance the following NN medico-marketing conferences: GLP-1 Masterclass (2019), Novomix Academy (2020), Virtual BDI (2021), Premix Summit (2022), Novomix Academy (2023).
• Achieved outstanding sales performance and received numerous marketing awards. A few of them are:

- NN EWA-BU Best Sales Achiever for Novorapid (166%), Tresiba (120%) and GLP-1RA(336%) portfolios H1 2023.

- NN Middle Africa Best Sales Achiever for GLP-1RA portfolio (178%) FY (Full Year) 2022.

- NN EWA-BU Best Sales Achiever for Human Insulin (85%) and GLP-1RA (156%) portfolios H1 2022.

- NN Middle Africa Overall Best Sales Achiever (134% achieved Vs budget) FY 2020.

• Grew my market segment by 11% in one year by employing qualitative and quantitative analysis in business decisions.
• Built effective and sustainable relationships with prescribers and customers.
• These relationships, driven primarily by pharmacological, clinical and scientific communication of company brands and oral presentation, enhanced brand experience and low customer attrition and I was awarded Best Presentation Skill Medical Representative 2018.

• Grew sales by 8% in less than one year through strategic marketing.
• Designed a stock tracking method that reduced quantities of out-of-date medications by 65%.
• Extensively coached and managed staff of 6 personnel.
• I also supervised recruitment and training of 3 staff.